Transcriptional activation of H-ras, K-ras and N-ras proto-oncogenes in human bladder tumors

Cancer Letters

Volumn 107, Issue 2, 1996, Pages 241-247

  Vageli, D ^a   Kiaris, H ^a   Delakas, D ^b   Anezinis, P ^b   Cranidis, A ^b   Spandidos, D A ^a,b  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Bladder carcinoma; H ras; K ras and N ras oncogenes; Overexpression; RT PCR

Indexed keywords

BETA ACTIN; COMPLEMENTARY RNA; RNA;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; ONCOGENE H RAS; ONCOGENE K RAS; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0030598164     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04372-8     Document Type: Article

References (35)

1. [1] Barbacid, M. (1987) ras genes, Annu. Rev. Biochem., 56, 779-827.
2. [2] Boss, J.L. (1989) ras oncogenes in human cancer: a review, Cancer Res., 49, 4682-4689.
3. [3] Spandidos, D.A. and Anderson, M.L.M. (1989) Oncogenes and oncosuppressor genes: their involvement in cancer, J. Pathol., 157, 1-10,
4. [4] Field, J.K. and Spandidos, D.A. (1990) The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review), Anticancer Res., 10, 1-22.
5. [5] Spandidos, D.A. and Lang, J.C. (1989) In vitro cell transformation by ras oncogenes, CRC Crit. Rev. Oncol., 1, 195-209.
6. [6] Raghavan, D., Shipley, W.U., Garnick, M.B., Russelli, P.J. and Richie, J.P. (1990) Biology and management of bladder cancer (review), N. Engl. J. Med., 322, 1129-1138.
7. [7] Ooi, A., Herz, F., Ii, S., Cordon-Cardo, C., Fradet, Y., Mayall, B.H. and Marker, N. (1994) H-ras codon 12 mutation in papillary tumors of the urinary bladder, A retrospective study. Int. J. Oncol., 4, 85-90.
8. [8] Sidransky, D., von Eschenbach, A., Tsai, Y.C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S.R., Frost, P. and Vogelstein, B. (1991) Identification of p53 gene mutations in bladder cancers and urine samples, Science, 252, 706-709.
9. [9] Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T. and Terada, M. (1992) Frequent association of p53 gene mutation in invasive bladder cancer, Cancer Res., 52, 1393-1398.
10. [10] Cordon-Cardo, C., Dalbagni, G., Saez, G.T., Oliva, M.R., Zhang, Z.F., Rosai, J., Reuter, V. and Pellicer, A. (1994) p53 mutations in human bladder cancer: genotypic versus phenotypic patterns, Int. J. Cancer, 56, 347-353.
11. [11] Furihata, M., Inoue, K., Ohtsuki, Y., Hashimoto, H., Terao, N. and Fujita, Y. (1993) High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder, Cancer Res., 53, 4823-4827.
12. [12] Sarkis, A.S., Dalbagni, G., Cordon-Cardo, C., Zhang, Z.F., Sheinfeld, S., Fair, W.R., Herr, W.H. and Renter, V.E. (1993) Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease prognosis, J. Natl. Cancer Inst., 85, 53-59.
13. [13] Tsai, Y.C., Nichols, P.W., Hiti, A.L., Williams, Z., Skinner, D.G. and Jones, P.A. (1990) Allelic losses of chromosome 9, 11 and 17 in human bladder cancer, Cancer Res., 50, 44-47.
14. [14] Fearon, E.R., Feinberg, A., Hamilton, S.H. and Volgestein, B. (1985) Loss of genes on the short arm of chromosome 11 in bladder cancer, Nature, 318, 377-380.
15. [15] Brewster, S.F., Gingell, J.C., Browne, S. and Brown, K.W. (1994) Loss of heterozygosity on chromosome 18q is associated with muscle invasive transitional cell carcinoma of the bladder, Br. J, Cancer, 70, 697-700.
16. [16] Krontiris, T.G., Delvin, B., Karp, D.D., Robert, N.J. and Risch, N. (1993) An association between the risk of cancer and mutations in the HraI minisatellite locus, N. Engl. J. Med., 329, 517-523.
17. [17] Gonzalez-Zlueta, M., Ruppert, J.M., Tokino, K., Tsai, Y.C., Spruck III, C.H., Miyao, N., Nichols, P.W., Hermann, G.G., Horn, T., Steven, K., Summerhayes, I.C., Sidransky, D. and Jones, P.A. (1993) Microsatellite instability in bladder cancer, Cancer Res., 53, 5620-5623.
18. [18] Kotsinas, A., Vageli, D., Varakliotou, A., Anezinis, P., Cranidis, A. and Spandidos, D.A. (1994) Genomic instability and LOH at two polymorphic sites in the H-ras gene, Int. J. Oncol., 5, 1249-1253.
19. [19] Capon, D.J., Chen, E.Y., Levinson, A.D., Seeburg, P.H. and Goeddel, D.V. (1983) Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue, Nature, 302, 33-37.
20. [20] Knowles, M.A. and Williamson, M. (1993) Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphisms and direct sequencing, Cancer Res., 53, 133-139.
21. [21] Levesque, P., Ramchurren, N., Saini, K., Joyce, A., Libertino, J. and Summerhayes, I.C. (1993) Screening of human bladder tumors and urine sediments for the presence of H-ras mutations, Int J Cancer, 55, 785-790.
22. [22] Fujita, J., Srivastava, S.K., Kraus, M.H., Rhim, J.S., Tronick, S.R. and Aaronson, S.A. (1985) Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors, Proc. Natl. Acad. Sci. USA, 82, 3849-3853.
23. [23] Czerniak, B., Deitch, D., Simmons, H., Etkind, P., Herz, F. and Koss, L.G. (1990) Ha-ras gene codon 12 mutations and DNA ploidy in urinary bladder, Br. J. Cancer, 62, 762-763.
24. [24] Haliassos, A., Liloglou, T., Likourinas, M., Doumas, C., Ricci, N. and Spandidos, D.A. (1992) H-ras oncogene mutations in the urine of patients with bladder tumors: description of a non-invasive method for the detection of neoplasia, Int. J. Oncol., 1, 731-734.
25. [25] Burchill, S.A., Lunec, J., Mellon, K. and Neal, D.E. (1991) Analysis of H-ras mutations in primary bladder tumors, Br. J. Cancer, 63 (Suppl. 3), 62.
26. [26] Spandidos, D.A., Karaiossifidi, H., Malliri, A., Linardopoulos, S., Vassilaros, S., Tsikkinis, A. and Field, J.K. (1992) Expression of Ras Rb1 and p53 proteins in human breast cancer, Anticancer Res., 12, 81-90.
27. [27] Spandidos, D.A. and Kerr, I.B. (1984) Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum, Br. J. Cancer, 49, 681-688.
28. [28] Kiaris, H., Spandidos, D.A., Jones, A.S., Vaughan, E.D. and Field, J.K. (1995) Mutations, expression and genomic instability of the H-ras proto-oncogene in squamous cell carcinomas of the head and neck, Br. J. Cancer, 72, 123-128.
29. [29] Spandidos, D.A., Lamothe, A. and Field, J.K. (1985) Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumours, Anticancer Res., 5, 221-224.
30. [30] Scambia, G., Catozzi, L., Benedetti-Panici, P., Ferrandina, G., Almadori, G., Paludetti, G., Cadoni, G., Distefano, M., Piffanelli, A., Manscuso, S. and Maurizi, M. (1994) Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues: correlation with histopathological features and epidermal growth factor receptors, Br. J. Cancer, 69, 995-999.
31. [31] Viola, M.V., Fromovitz, F., Oravez, S., Deb, S. and Schlom, J. (1985) Ras oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma, J. Exp. Med., 161, 1213-1218.
32. [32] Ting-jie, M., Ze, W. and Nianli, S. (1991) Correlation between the expression of the p21 ras oncogene product and the biological behavior of bladder tumors, Eur. Urol., 20, 307-310.
33. [33] Leon, J., Guerrero, I. and Pellicer, A. (1987) Differential expression of the ras gene family in mice, Mol. Cell. Biol., 7, 1535-1540.
34. [34] Kotsinas, A., Kiaris, H. and Spandidos, D.A. (1994) A method to detect and quantitate the expression of normal versus mutant H-ras transcripts at codon 12, Int. J. Oncol., 5, 479-483.
35. [35] Brenner, C.A., Tam, A.W., Nelson, P.A., Engleman, E.G., Suzuki, N., Fry, K.E. and Larrick, J.W. (1989) Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells, BioTechniques, 7, 1096-1103.